Loading
Min-Hee Ryu is a gastric cancer and GIST trialist central to the Asian arms of ramucirumab, pembrolizumab, and zolbetuximab studies.
Min-Hee Ryu is Professor of Medical Oncology at Asan Medical Center in Seoul, specialising in gastric cancer and gastrointestinal stromal tumours. He co-leads gastrointestinal oncology at the centre and has been central to the Asian arms of the ramucirumab, pembrolizumab and zolbetuximab studies, with steering roles in RAINBOW-Asia, GLOW and the KEYNOTE gastric trials, as well as in studies of tyrosine kinase inhibitor sequencing in GIST. His publications include the GLOW trial of zolbetuximab plus CAPOX in Claudin 18.2-positive gastric or gastro-oesophageal junction adenocarcinoma. His interests are gastric cancer, GIST and clinical trials.
| Title | Journal | Year |
|---|---|---|
| Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or GEJ adenocarcinoma (GLOW) | Nature Medicine | 2023 |
Shares Asan Medical Center, SPOTLIGHT & GLOW, Zolbetuximab, Claudin 18.2.
Shares SPOTLIGHT & GLOW, Zolbetuximab, Claudin 18.2, Gastric & gastro-oesophageal junction cancer.
Shares SPOTLIGHT & GLOW, Zolbetuximab, Gastric & gastro-oesophageal junction cancer.
Shares Zolbetuximab, Claudin 18.2, Gastric & gastro-oesophageal junction cancer.
Shares SPOTLIGHT & GLOW, Zolbetuximab, Claudin 18.2, Gastric & gastro-oesophageal junction cancer.
Shares Zolbetuximab, Claudin 18.2, Gastric & gastro-oesophageal junction cancer.
Shares SPOTLIGHT & GLOW, Zolbetuximab, Claudin 18.2, Gastric & gastro-oesophageal junction cancer.
Shares Claudin 18.2, Ramucirumab, Gastric & gastro-oesophageal junction cancer.